Table 2: Subgroup analysis of Age, GCS, Volume and clot location.
| - |
n=117
|
Mortality
|
P
|
Favourable Outcome
|
Unfavourable Outcome
|
P Value
|
|
Age
|
- |
- |
- |
- |
- |
- |
| < 40 |
6 |
0 |
0.176 |
3(50%) |
3(50%) |
0.702 |
| 40- 60 |
46 |
11(23.9%) |
- |
25(71.4%) |
10(28.6%) |
- |
| 60- 70 |
41 |
12(29.3%) |
- |
21(72.4%) |
8(27.6%) |
- |
| 70 > |
24 |
10(40%) |
- |
9(64.3%) |
5(35.7%) |
- |
|
Sex
|
- |
- |
- |
- |
- |
- |
| Male |
67 |
25(36.8%) |
0.011
|
30(71.4%) |
12(28.6%) |
0.637 |
| Female |
50 |
8(15.7%) |
|
28(66.7%) |
14(33.3%) |
|
|
GCS
|
- |
- |
- |
- |
- |
- |
| GCS < 8 |
23 |
12(52.2%) |
0.001 |
6(54.5%) |
5(45.5%) |
0.231 |
| 9 to 12 |
36 |
13(35.1%) |
- |
14(60.9%) |
9(39.1%) |
- |
| 12> |
58 |
8(13.6%) |
|
38(76%) |
12(24%) |
- |
| Mean GCS |
- |
- |
- |
- |
- |
- |
|
Clot volume
|
- |
|
- |
- |
- |
- |
| < 20 ml |
105 |
24(22.4%) |
<0.001
|
58(71.6%) |
23(28.4%) |
0.031
|
| 20-40 ml |
11 |
9(81.8%) |
- |
0 |
2(100%) |
- |
| 40-60 ml |
1 |
0 |
- |
0 |
1(00%) |
- |
|
Clot Location
|
- |
- |
- |
- |
|
- |
|
Medial
|
13 |
4(30.8%) |
0.564 |
8(88.9%) |
1(11.1%) |
0.076 |
|
Lateral
|
53 |
13(24.5%) |
- |
28(70%) |
12(30%) |
- |
|
Anterior
|
3 |
0 |
- |
0 |
3(100%) |
- |
|
Posterior
|
19 |
5(26.3%) |
- |
10(71.4%) |
4(28.6%) |
- |
|
Global
|
29 |
11(37.9%) |
- |
12(66.7%) |
6(33.3%) |
- |